Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $117.2252W HIGH $239.29
Volume
65.28 K
Value Traded
27.06 M
Short % Float
6.42%
+0.71%Week
+0.93%1 Month
+9.06%3 Month
+40.6%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
3.60 B
EPS (TTM)
8.96
P/E Ratio
25.67
Ent. Value
3.56 B
Total Shares
15.66 M
Float Shares
12.72 M
Insiders
18.79%
Institutions
65.88%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
NHC Catalyst Timeline
Dated clinical, regulatory and corporate events for National Healthcare Corp.
Catalyst Timeline
Dated clinical, regulatory & corporate events for National Healthcare Corp.
29Total events
1Upcoming
4Tier-1 (high impact)
2012 to 2026Coverage
Event history 28
●Quarterly UpdateCorporate
Scilex announces dividend of Semnur common stock with record date June 1, 2026 and payment date June 15, 2026
●Quarterly UpdateCorporate
NHC Reports Second Quarter Earnings for period ended June 30, 2017
◆Management ChangeCorporate
R. Michael Ussery appointed as President and COO, effective January 1, 2017
●Quarterly UpdateCorporate
NHC Reports Third Quarter Earnings for period ended September 30, 2016
●Quarterly UpdateCorporate
NHC Reports Second Quarter Earnings for period ended June 30, 2016
●Quarterly UpdateCorporate
NHC Reports Third Quarter Earnings for period ended September 30, 2015
●Quarterly UpdateCorporate
NHC Reports Second Quarter Earnings for period ended June 30, 2014
●Quarterly UpdateCorporate
NHC Reports First Quarter Earnings for period ended March 31, 2014
▲Quarterly UpdateCorporate
NHC Reports Second Quarter Earnings for quarter ended June 30, 2013
●Quarterly UpdateCorporate
NHC Reports Third Quarter Earnings for period ended September 30, 2012
●Quarterly UpdateCorporate
NHC Reports Second Quarter Earnings for period ended June 30, 2012
Past FDA Catalysts and PDUFA Decisions
How NHC actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
Pipeline Score
Pipeline Value
Valuation Signal
1
Drugs Scored
rNPV / MCap
Top Drug
Top 87%
Small Cap(rank 572 of 657)
Percentile Rank
| Drug | Indication | Phase | PTRS | rNPV | Status | Enroll | Velocity | Design | Est. Completion | ML Signal | Last Change |
|---|
Clinical Trial Results
Readouts, endpoints and source filings for every NHC program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Dodson Vicki LOfficer (Sr.VP Patient Srvcs) | Sell | -4,834.001 10,725.545 held | $225.00 | 09/22/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in NHC
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in NHC for Q2 2026. | ||||
NHC Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2027-05-21 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How NHC ranks across every disease it competes in
Competitive Position is a premium feature
See how NHC ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialNHC News
-NHC
Aug 7, 2026NHC Reports Second Quarter 2026 Earnings
National HealthCare Corporation (NHC) reported a net operating revenue of $408 million for Q2 2026, marking an 8.8% increase from $375 million in Q2 2025. This growth is largely attributed to the acquisition of five skilled nursing facilities on June 1, 2026. The company continues to strengthen its position in the senior health care market.
Read more →-NHC
Aug 7, 2026NHC Announces Common Dividend
National HealthCare Corporation (NHC) has announced a quarterly dividend of 67 cents per common share. This dividend will be paid to shareholders of record on September 30, 2026, with payment scheduled for October 30, 2026. This announcement underscores NHC's commitment to returning value to its shareholders.
Read more →-NHC
Jul 1, 2026NHC Completes Acquisition of Thirty-Five NHI Facilities
NHC has successfully completed the acquisition of thirty-five facilities from NHI. This strategic move is expected to enhance NHC's operational capacity and service offerings. The acquisition aligns with NHC's growth strategy in the healthcare sector, although specific details on the facilities' locations and operational changes were not disclosed.
Read more →-NHC
Jun 23, 2026McKesson Selects Moore, Oklahoma for a State-of-the-Art Regional Distribution Center Positions Cleveland County as a National Healthcare Supply Chain Hub
McKesson Corporation has chosen Moore, Oklahoma for a new regional distribution center, enhancing the healthcare supply chain's efficiency. This facility will replace an existing center, creating over 200 jobs and supporting the distribution of pharmaceuticals across multiple states. The investment marks a significant step for Cleveland County's economic development strategy and positions the region as a hub for healthcare logistics.
Read more →-NHC
Jun 17, 2026National Healthcare Properties Announces Preliminary Results of its Series A and Series B Preferred Stock Self Tender Offers
National Healthcare Properties, Inc. announced preliminary results for its self-tender offers for Series A and Series B preferred stocks, with approximately 556,049 Series A and 566,229 Series B shares tendered. The company plans to purchase these shares for about $25.25 million. The final number of shares is pending verification by Computershare, the depositary for the offers.
Read more →-NHC
Aug 9, 2017NHC Announces $ 25 Million Stock Repurchase Program For release
NHC Announces $25 Million Stock Repurchase Program For release: August 9, 2017 Contact: John K. Lines, SVP/General Counsel Phone: (615) 890-2020 MURFREESBORO, Tenn. - National HealthCare Corporation (NYSE American: NHC), announces that its Board of Directors, at a regularly s
Read more →-NHC
Aug 4, 2017For release
For release: August 4, 2017 Contact: John K. Lines, SVP Phone: (615) 890-2020 NHC Reports Second Quarter Earnings MURFREESBORO, Tenn. -- National HealthCare Corporation (NYSE-American: NHC), the nation's oldest publicly traded senior health care company, today announced net o
Read more →-NHC
Nov 4, 2016For release: November 3, 2016
For release: November 3, 2016 Contact: John K. Lines, SVP/General Counsel Phone: (615) 890-2020 NHC Reports Third Quarter Earnings MURFREESBORO, Tenn. -- National HealthCare Corporation (NYSE MKT: NHC), the nation's oldest publicly traded senior health care company, today ann
Read more →-NHC
Aug 9, 2016NHC Announces $25 Million Stock Repurchase Program For release
NHC Announces $25 Million Stock Repurchase Program For release: August 9, 2016 Contact: Gerald Coggin, Sr. VP of Corporate Relations Phone: (615) 890-2020 MURFREESBORO, Tenn. - National HealthCare Corporation (NYSE MKT: NHC), announces that its Board of Directors, at a regula
Read more →-NHC
Aug 8, 2016For release: August 5, 2016
For release: August 5, 2016 Contact: Gerald Coggin, Sr. VP of Corporate Relations Phone: (615) 890-2020 NHC Reports Second Quarter Earnings MURFREESBORO, Tenn. -- National HealthCare Corporation (NYSE MKT: NHC), the nation's oldest publicly traded senior health care company,
Read more →-NHC
May 3, 2016Gerald Coggin, Sr.
For release: May 3, 2016 Contact: Gerald Coggin, Sr. VP of Corporate Relations Phone: (615) 890-2020 NHC Reports First Quarter Earnings MURFREESBORO, Tenn. -- National HealthCare Corporation (NYSE MKT: NHC), the nation's oldest publicly traded long-term health care company, t
Read more →-NHC
Feb 22, 2016For release: February 19, 2016
For release: February 19, 2016 Contact: Gerald Coggin, Sr. VP of Corporate Relations Phone: (615) 890-2020 NHC Reports Year End Earnings MURFREESBORO, Tenn. -- National HealthCare Corporation (NYSE MKT: NHC), the nation's oldest publicly traded long-term health care company,
Read more →-NHC
Feb 12, 2016For release: February 12, 2016
For release: February 12, 2016 Contact: Gerald Coggin, Senior VP of Corporate Relations Phone: (615) 890-2020 NHC Announces Common Dividend MURFREESBORO, Tenn. -- National HealthCare Corporation (NYSE MKT: NHC), the nation's oldest publicly traded long-term health care compan
Read more →About National Healthcare Corp.
Headquarters100 E. VINE ST, MURFREESBORO, TN, 37130
BIOPHARMAWATCH ELITE PLUS
Trade the next NHC catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime